Kurtanović, N.; Tomašević, N.; Matić, S.; Proia, E.; Sabatino, M.; Antonini, L.; Mladenović, M.; Ragno, R.
Human Estrogen Receptor Alpha Antagonists, Part 3: 3-D Pharmacophore and 3-D QSAR Guided Brefeldin A Hit-to-Lead Optimization toward New Breast Cancer Suppressants. Molecules 2022, 27, 2823.
https://doi.org/10.3390/molecules27092823
AMA Style
Kurtanović N, Tomašević N, Matić S, Proia E, Sabatino M, Antonini L, Mladenović M, Ragno R.
Human Estrogen Receptor Alpha Antagonists, Part 3: 3-D Pharmacophore and 3-D QSAR Guided Brefeldin A Hit-to-Lead Optimization toward New Breast Cancer Suppressants. Molecules. 2022; 27(9):2823.
https://doi.org/10.3390/molecules27092823
Chicago/Turabian Style
Kurtanović, Nezrina, Nevena Tomašević, Sanja Matić, Elenora Proia, Manuela Sabatino, Lorenzo Antonini, Milan Mladenović, and Rino Ragno.
2022. "Human Estrogen Receptor Alpha Antagonists, Part 3: 3-D Pharmacophore and 3-D QSAR Guided Brefeldin A Hit-to-Lead Optimization toward New Breast Cancer Suppressants" Molecules 27, no. 9: 2823.
https://doi.org/10.3390/molecules27092823
APA Style
Kurtanović, N., Tomašević, N., Matić, S., Proia, E., Sabatino, M., Antonini, L., Mladenović, M., & Ragno, R.
(2022). Human Estrogen Receptor Alpha Antagonists, Part 3: 3-D Pharmacophore and 3-D QSAR Guided Brefeldin A Hit-to-Lead Optimization toward New Breast Cancer Suppressants. Molecules, 27(9), 2823.
https://doi.org/10.3390/molecules27092823